ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
7 hedge funds and large institutions have $789K invested in Avenue Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BRWA
1
B. Riley Wealth Advisors
Boca Raton,
Florida
|
$220K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $353K | 98,641 | +3,915 | +4% |
|
|
BRWA
2
B. Riley Wealth Advisors
Boca Raton,
Florida
| $220K | 61,250 | -1,000 | -2% |
|
|
FWM
3
Frontier Wealth Management
Kansas City,
Missouri
| $72K | 20,000 | – | – |
|
4
BlackRock
New York
| $63K | 17,686 | +1,046 | +6% |
|
|
GPCM
5
Granite Point Capital Management
Boston,
Massachusetts
| $61K | 17,121 | +17,121 | New |
|
6
UBS Group
Zurich,
Switzerland
| $18K | 5,039 | +1,221 | +32% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2K | 626 | +626 | New |
|
8
Morgan Stanley
New York
| – | – | -10 | Closed |
|